A recent study found that apigenin decreased the DNA methylation status of the NRF2 promoter and inhibited the expression of DNMTS and HDACS, which restored the NRF2 expression and increased NQO1 expression levels in the preneoplastic JB6 P+ cell line, demonstrating its activity against skin cancer [91]. This evidence concerns the gene NFE2L2 and skin neoplasm.